USCR (31.36) looks very cheap going by analyst estimates for H2 2018 and 2019 .... it trades at around 6x '19 estimates .... the problem is that they've missed estimates by large amounts the past 3 reports and they're probably going to miss badly again for Q3 judging by the stock action ....
At this point it's a HOLD for me, definitely not a BUY until after I see the Q3 report. Hopefully it won't be as bad as the stock action suggests.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.